ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1308

Measuring the Educational Impact of a Collaboration Between RheumMadness and TheMednet

Nina Couette1, Herveen Kaur Singh2, Nadine Housri3, Eric Wilson4, Benjamin Lueck5, Sabahat Usmani6, Laura Arneson7, Meredith Balbach8, Lauren Phillips9, John Kellogg5, Courtney Bair10, Michael Macklin11, Iman Qaiser12, Amanda Rodriguez13, Akrithi Garren14, Matthew Sparks15, Lisa Criscione-Schreiber5, Guy Katz16, David Leverenz15 and Melissa Briones17, 1Genesis Healthcare System, Columbus, OH, 2theMednet, New York, NY, 3Yale School of Medicine, New Haven, CT, 4Duke University Hospital, Durham, NC, 5Duke University School of Medicine, Durham, NC, 6WEISS Memorial Hospital, Chicago, IL, 7Northwestern University, Chicago, IL, 8Vanderbilt University, Nashville, TN, 9University of Michigan, Ann Arbor, MI, 10Duke Univerisity, Durham, 11University of Chicago, Chicago, IL, 12Choctaw Nation of Oklahoma Health Services Authority, McKinney, TX, 13Main Line Health, Wynnewood, PA, 14MedStar/Georgetown Washington Hospital Center, Silver Spring, MD, 15Duke University, Durham, NC, 16Massachusetts General Hospital, Boston, MA, 17Loyola University, Maywood, IL

Meeting: ACR Convergence 2024

Keywords: Education, education, medical

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Professional Education Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: theMednet.org is an online educational forum in which physicians submit clinical questions that are answered by experts in the field. RheumMadness is an online tournament of rheumatology concepts that engages learners through a community of inquiry framework. We sought to measure the educational impact of collaborative use of these learning platforms using data from participants redeeming continuing medical education (CME)

Methods: The 2024 RheumMadness tournament consisted of 16 teams of competing concepts that were presented as scouting reports written by trainees and rheumatologists. 14 clinically focused questions specific to RheumMadness content were published on theMednet along with answers from experts and relevant polling questions. Leadership teams from RheumMadness and theMednet publicized updates about each other’s initiatives on their respective online platforms. At the conclusion of the tournament, CME and maintenance of certification (MOC) data for questions related to RheumMadness were analyzed.

Results: During the tournament period there were 292 CME credit claims for 101 unique practicing rheumatologists. Of those claims, in regard to impact on clinical practice, 41% of respondents stated they gained a deeper understanding of a topic, 35% learned something new, 12% stated there was no impact, 8% stated they understand how to apply what they know to clinical practice and 4% responded “other” (Figure 1). Impact data for individual questions was also evaluated (Figure 2). The question with the greatest impact on learning something new was “Do you generally recommend starting nintedanib prior to immunosuppressive therapy in a patient with CTD-ILD”. The question with the greatest impact on application to clinical practice was “How do you counsel patients on the benefit of diet and exercise in OA that motivates them in a way to comply?”. In regard to application of knowledge in clinical practice, the majority of respondents (73%) reported questions confirmed their practice, 14% reported it changed their practice, 6% reported they needed more information, 5% reported “other” and 2% reported their practice differs and they disagreed with the question responses (Figure 1). The question with the highest reported change in clinical practice was “How do you counsel patients who ask if there are any dietary modifications they can make to help control their autoimmune disease?” with 38% of rheumatologists reporting this changed their practice (Figure 3).  Overall, there was a range of 1 to 36 respondents who claimed CME credit per question. There were 196 unique maintenance of certification (MOC) responses. Themes included improved understanding of diagnosis, treatment and management of rheumatologic diseases.

Conclusion: The question and answer format of theMednet is an effective way to educate practicing rheumatologists on important clinical concepts in their field.  Collaboration between theMednet and RheumMadness tournament led to a measurable impact on learners’ understanding of topics, knowledge of new topics and application of concepts to clinical practice.

Supporting image 1

Figure 1. Percent of Responses for all questions in RheumMadness 2024

Supporting image 2

Figure 2. Impact – Responses by Question

Supporting image 3

Figure 3. Application – Responses by Question


Disclosures: N. Couette: None; H. Kaur Singh: theMednet, 3; N. Housri: theMednet, 3, 8; E. Wilson: None; B. Lueck: None; S. Usmani: None; L. Arneson: None; M. Balbach: None; L. Phillips: None; J. Kellogg: None; C. Bair: None; M. Macklin: None; I. Qaiser: None; A. Rodriguez: None; A. Garren: None; M. Sparks: None; L. Criscione-Schreiber: UCB, 5; G. Katz: Amgen, 1, Evolve Medical Education, 6, Sana, 5, Sanofi, 5, Zenas, 5; D. Leverenz: Pfizer, 5, Rheumatology Research Foundation, 5, Sanofi, 2, UCB, 2; M. Briones: theMednet.org, 3, 11.

To cite this abstract in AMA style:

Couette N, Kaur Singh H, Housri N, Wilson E, Lueck B, Usmani S, Arneson L, Balbach M, Phillips L, Kellogg J, Bair C, Macklin M, Qaiser I, Rodriguez A, Garren A, Sparks M, Criscione-Schreiber L, Katz G, Leverenz D, Briones M. Measuring the Educational Impact of a Collaboration Between RheumMadness and TheMednet [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/measuring-the-educational-impact-of-a-collaboration-between-rheummadness-and-themednet/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/measuring-the-educational-impact-of-a-collaboration-between-rheummadness-and-themednet/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology